Skip to main content

Table 2 Results of Meta-analysis of systolic blood pressure

From: Clinical and economic outcomes of hospital pharmaceutical care: a systematic review and meta-analysis

Study | SMD [95% Conf. Interval] % Weight
Carter (1997) [8] | -0.173 − 0.723 0.377 10.66
Carter (2009) [15] | -0.596 −0.796 − 0.396 16.73
Schumacher (2018) | -0.696 −0.927 −0.465 16.26
Korcegez (2017) | -0.574 −0.899 − 0.250 14.65
Domingues (2017) [40] | -0.301 −0.732 0.129 12.73
Javaid (2019) [42] | -1.456 −1.844 −1.067 13.49
Shao (2017) | -0.148 −0.426 0.131 15.47
D + L pooled RR | -0.573 −0.851 −0.295 100.00
  1. Heterogeneity chi-squared = 33.52 (d.f. = 6) p = 0.000.
  2. I-squared (variation in SMD attributable to heterogeneity) =82.1%.
  3. Estimate of between-study variance Tau-squared = 0.1096.
  4. Test of SMD = 0: z = 4.04 p = 0.000.
  5. The significance level of the combined effect quantity test: 0.05.
  6. The significance level of the heterogeneity test: 0.1.
  7. Heterogeneity test: p > 0.1, no heterogeneity was considered; p < 0.1, heterogeneity was considered.